Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world cohort.
- Resource Type
- Article
- Source
- Infection; Aug2023, Vol. 51 Issue 4, p851-858, 8p, 3 Charts
- Subject
DRUG efficacy LENGTH of stay in hospitals COVID-19 TOCILIZUMAB JANUS kinases HOSPITAL mortality ARTIFICIAL respiration HOSPITAL care NEUROTRANSMITTER uptake inhibitors PATIENT safety EVALUATION - Language
- ISSN
- 03008126